FDA Panel Considers Johnson & Johnson COVID-19 Vaccine Boosters
Newsy
The FDA will use its advisers' recommendations to decide whether to authorize boosters for both J&J and Moderna, likely next week.
U.S. health advisers on Friday tackled who should get boosters of Johnson & Johnson's single-shot COVID-19 vaccine and when — and whether using a competing brand for the second dose might provide better protection.
The push for boosters kicked off last month after the Food and Drug Administration authorized third doses of the Pfizer vaccine for seniors and younger adults with health problems, jobs or living conditions that place them at higher risk from the coronavirus. On Thursday, an FDA advisory panel unanimously recommended a half-dose booster of the similar Moderna vaccine for the same groups.
Related StoryFDA Panel Endorses Moderna COVID Vaccine Booster Shot
